Calidi Biotherapeutics
CLDI
CLDI
35 hedge funds and large institutions have $3.09M invested in Calidi Biotherapeutics in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.26% more ownership
Funds ownership: 0.49% → 1.74% (+1.3%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $9K
Holders
35
Holding in Top 10
–
Calls
–
Puts
$9K
Top Buyers
| 1 | +$1.88M | |
| 2 | +$270K | |
| 3 | +$165K | |
| 4 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
+$141K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$52K |
Top Sellers
| 1 | -$157K | |
| 2 | -$38.5K | |
| 3 | -$20.1K | |
| 4 |
DWM
Drive Wealth Management
Lehi,
Utah
|
-$19.8K |
| 5 |
HF
HRT Financial
New York
|
-$18K |
